ARKEMA (AKE.PA) Stock Fundamental Analysis
Europe - EPA:AKE - FR0010313833 - Common Stock
49.78 EUR
-0.72 (-1.43%)
We assign a fundamental rating of 5 out of 10 to AKE. AKE was compared to 69 industry peers in the Chemicals industry. Both the profitability and the financial health of AKE get a neutral evaluation. Nothing too spectacular is happening here. AKE has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year AKE was profitable.
AKE had a positive operating cash flow in the past year.
AKE had positive earnings in each of the past 5 years.
Each year in the past 5 years AKE had a positive operating cash flow.
1.2 Ratios
AKE's Return On Assets of 1.51% is in line compared to the rest of the industry. AKE outperforms 53.62% of its industry peers.
The Return On Equity of AKE (2.90%) is comparable to the rest of the industry.
AKE has a Return On Invested Capital of 3.44%. This is comparable to the rest of the industry: AKE outperforms 52.17% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AKE is in line with the industry average of 6.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROIC | 3.44% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
1.3 Margins
AKE has a Profit Margin (2.22%) which is comparable to the rest of the industry.
AKE's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 6.35%, AKE is in line with its industry, outperforming 59.42% of the companies in the same industry.
In the last couple of years the Operating Margin of AKE has declined.
With a Gross Margin value of 19.02%, AKE is not doing good in the industry: 72.46% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of AKE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% |
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
2. Health
2.1 Basic Checks
AKE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AKE has been increased compared to 1 year ago.
Compared to 5 years ago, AKE has less shares outstanding
AKE has a worse debt/assets ratio than last year.
2.2 Solvency
AKE has an Altman-Z score of 1.86. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.86, AKE is doing worse than 68.12% of the companies in the same industry.
The Debt to FCF ratio of AKE is 16.70, which is on the high side as it means it would take AKE, 16.70 years of fcf income to pay off all of its debts.
AKE has a Debt to FCF ratio (16.70) which is in line with its industry peers.
A Debt/Equity ratio of 0.50 indicates that AKE is somewhat dependend on debt financing.
The Debt to Equity ratio of AKE (0.50) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Altman-Z | 1.86 |
ROIC/WACC0.73
WACC4.69%
2.3 Liquidity
AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.73, AKE is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
A Quick Ratio of 1.92 indicates that AKE should not have too much problems paying its short term obligations.
AKE has a better Quick ratio (1.92) than 82.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.27%.
Measured over the past 5 years, AKE shows a small growth in Earnings Per Share. The EPS has been growing by 0.10% on average per year.
The Revenue has been growing slightly by 0.32% in the past year.
AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-38.27%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.21%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-7.55%
3.2 Future
AKE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.61% yearly.
Based on estimates for the next years, AKE will show a small growth in Revenue. The Revenue will grow by 2.08% on average per year.
EPS Next Y-35.91%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPS Next 5Y-1.61%
Revenue Next Year-4.84%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.39%
Revenue Next 5Y2.08%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.65 indicates a reasonable valuation of AKE.
92.75% of the companies in the same industry are more expensive than AKE, based on the Price/Earnings ratio.
AKE is valuated cheaply when we compare the Price/Earnings ratio to 25.47, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.15, the valuation of AKE can be described as very reasonable.
Based on the Price/Forward Earnings ratio, AKE is valued cheaper than 92.75% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.42. AKE is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.65 | ||
| Fwd PE | 8.15 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AKE is valued cheaply inside the industry as 92.75% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AKE is valued a bit cheaper than 76.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.68 | ||
| EV/EBITDA | 4.39 |
4.3 Compensation for Growth
A cheap valuation may be justified as AKE's earnings are expected to decrease with -4.81% in the coming years.
PEG (NY)N/A
PEG (5Y)98.72
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.74%, AKE is a good candidate for dividend investing.
In the last 3 months the price of AKE has falen by -21.34%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
AKE's Dividend Yield is rather good when compared to the industry average which is at 3.36. AKE pays more dividend than 91.30% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, AKE pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.74% |
5.2 History
On average, the dividend of AKE grows each year by 6.86%, which is quite nice.
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
AKE pays out 129.52% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of AKE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPA:AKE (11/20/2025, 5:36:15 PM)
49.78
-0.72 (-1.43%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners59.49%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.79B
Revenue(TTM)9.54B
Net Income(TTM)210.00M
Analysts73.33
Price Target71.27 (43.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.74% |
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-8.22%
PT rev (3m)-10.42%
EPS NQ rev (1m)-4.68%
EPS NQ rev (3m)-32.06%
EPS NY rev (1m)-7.1%
EPS NY rev (3m)-34.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.07%
Revenue NY rev (1m)-1.12%
Revenue NY rev (3m)-2.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.65 | ||
| Fwd PE | 8.15 | ||
| P/S | 0.4 | ||
| P/FCF | 16.68 | ||
| P/OCF | 3.73 | ||
| P/B | 0.52 | ||
| P/tB | 1.77 | ||
| EV/EBITDA | 4.39 |
EPS(TTM)5.16
EY10.37%
EPS(NY)6.11
Fwd EY12.27%
FCF(TTM)2.98
FCFY6%
OCF(TTM)13.36
OCFY26.83%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)98.72
Graham Number105.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROCE | 4.88% | ||
| ROIC | 3.44% | ||
| ROICexc | 3.86% | ||
| ROICexgc | 7.22% | ||
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% | ||
| FCFM | 2.4% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Debt/EBITDA | 2.56 | ||
| Cap/Depr | 95.75% | ||
| Cap/Sales | 8.36% | ||
| Interest Coverage | 17.14 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 108.1% | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 1.86 |
F-Score5
WACC4.69%
ROIC/WACC0.73
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.27%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.21%
EPS Next Y-35.91%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPS Next 5Y-1.61%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-7.55%
Revenue Next Year-4.84%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.39%
Revenue Next 5Y2.08%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year49.9%
EBIT Next 3Y20.73%
EBIT Next 5Y12.81%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%
ARKEMA / AKE.PA FAQ
What is the ChartMill fundamental rating of ARKEMA (AKE.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to AKE.PA.
What is the valuation status of ARKEMA (AKE.PA) stock?
ChartMill assigns a valuation rating of 6 / 10 to ARKEMA (AKE.PA). This can be considered as Fairly Valued.
How profitable is ARKEMA (AKE.PA) stock?
ARKEMA (AKE.PA) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ARKEMA (AKE.PA) stock?
The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 9.65 and the Price/Book (PB) ratio is 0.52.
How financially healthy is ARKEMA?
The financial health rating of ARKEMA (AKE.PA) is 5 / 10.